Fluorosurfactant-stabilized microfluidic droplets are widely used as pico- to nanoliter volume reactors in chemistry and biology. However, current surfactants cannot completely prevent inter-droplet transfer of small organic molecules encapsulated or produced inside the droplets. In addition, the microdroplets typically coalesce at temperatures higher than 80 °C. Therefore, the use of droplet-based platforms for ultrahigh-throughput combination drug screening and polymerase chain reaction (PCR)-based rare mutation detection has been limited. Here, we provide insights into designing surfactants that form robust microdroplets with improved stability and resistance to inter-droplet transfer. We used a panel of dendritic oligo-glycerol-based surfactants to demonstrate that a high degree of inter- and intramolecular hydrogen bonding, as well as the dendritic architecture, contribute to high droplet stability in PCR thermal cycling and minimize inter-droplet transfer of the water-soluble fluorescent dye sodium fluorescein salt and the drug doxycycline.
Creating a single surfactant that is open to manipulation, while maintaining its surface activity, robustness, and compatibility, to expand the landscape of surfactant-dependent assays is extremely challenging. We report an oxidation-responsive precursor with thioethers and multiple 1,2-diols for creating a variety of functional surfactants from one parent surfactant. Using these multifunctional surfactants, we stabilize microfluidics-generated aqueous droplets. The droplets encapsulate different components and immerse in a bioinert oil with distinct interfaces where an azide-bearing surfactant allow fishing of biomolecules from the droplets, aldehyde-bearing surfactant allow fabrication of microcapsules, and hydroxyl-bearing surfactants, with/without oxidized thioethers, allow monitoring of single-cell gene expression. Creating multifunctional surfactants poses opportunities for broad applications, including adsorption, bioanalytics, catalysis, formulations, coatings, and programmable subset of emulsions.
To this date, biosensing devices mainly based on two-dimensional (2D) assays such as enzyme-linked immunosorbent assay (ELISA) or 2D-microarrays are found on the market. In this article, we circumvent the drawbacks of 2D assays such as low loading capacity and protein denaturation, by producing a three-dimensional (3D) hydrogel array. As a proof of concept, we focus on antibody detection by peptides. A click reaction of polyethylene glycol (PEG) and dendritic polyglycerol (dPG) has produced one of the softest (G′ = 200 Pa) but relatively robust existing hydrogels comparable to cells. This customizable hydrogel is favorable for antibody diffusion and for peptide immobilization through bioorthogonal chemistry. An extensive study of the mechanical properties as a function of the PEG length has been conducted, which suggests, at both nano- and macro-scales, that an increase of the PEG length decreased the stiffness of the hydrogels and increased the mesh size, which correspondingly increased the diffusion rate of antibodies. The hydrogels exhibited a remarkable swelling ratio reaching up to 100 with a height expansion ratio up to 8. This specific and selective 3D model of detection has suggested a loading capacity seven times higher compared to 2D arrays, a higher sensitivity by 20% and a limit of detection up to 27 pg mL−1 for 3D assays setting the limits as low as that of other antibody binding methods such as ELISA, whereas the limit of detection for 2D slides is 0.5 μg mL−1.
We decoupled the influence of different spatial geometries of oligoglycerol-based head groups and contributed to the goal of rational fluorosurfactant design for droplet microfluidics-based water-in-oil emulsions and suited applications.